Application of the Machine-Learning Model to Improve Prediction of Non-Sentinel Lymph Node Metastasis Status Among Breast Cancer Patients
Authors:
Open Access
- 25 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 797377
Abstract
Background: Performing axillary lymph node dissection (ALND) is the current standard option after a positive sentinel lymph node (SLN). However, whether 1–2 metastatic SLNs require ALND is debatable. The probability of metastasis in non-sentinel lymph nodes (NSLNs) can be calculated using nomograms. In this study, we developed an individualized model using machine-learning (ML) methods to select potential variables, which influence NSLN metastasis.Materials and Methods: Cohorts of patients with early breast cancer who underwent SLN biopsy and ALND between 2012 and 2021 were created (training cohort, N 157 and validation cohort, N 58) for the development of the nomogram. Three ML methods were trained in the training set to create a strong predictive model. Finally, the multiple iterations of the least absolute shrinkage and selection operator regression method were used to determine the variables associated with NSLN status.Results: Four independent variables (positive SLN number, absence of lymph node hilum, lymphovascular invasion (LVI), and total number of SLNs harvested) were combined to generate the nomogram. The area under the receiver operating characteristic curve (AUC) value of 0.759 was obtained in the entire set. The AUC values for the training set and the test set were 0.782 and 0.705, respectively. The Hosmer-Lemeshow test of the model fit accuracy was identified with p = 0.759.Conclusion: This study developed a nomogram that incorporates ultrasound (US)-related variables using the ML method and serves to clinically predict the non-metastatic status of NSLN and help in the selection of the appropriate treatment option.Keywords
This publication has 43 references indexed in Scilit:
- Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph nodeEuropean Journal of Cancer, 2013
- International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast CancerJNCI: Journal of the National Cancer Institute, 2012
- Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: entinel node vs bservation after axillary ltraSou )The Breast, 2012
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialThe Lancet Oncology, 2010
- Breast cancer risk estimation with artificial neural networks revisitedCancer, 2010
- New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patientsBMC Cancer, 2008
- A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positiveBritish Journal of Surgery, 2008
- Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited*Critical Care Medicine, 2007
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerNew England Journal of Medicine, 2003
- Evaluating the yield of medical testsJAMA, 1982